Shiga, Japan

Totaro Oka

This inventor holds 2 USPTO granted patents. Top assignee: Toray Industries, Inc.. Active years: 1987-1988.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1987-1988

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Totaro Oka

Introduction

Totaro Oka is a notable inventor based in Shiga, Japan. He has made significant contributions to the field of endotoxin detoxification, with a focus on developing materials and methods that enhance safety and efficacy in medical treatments. His work has led to the filing of multiple patents, showcasing his innovative approach to solving complex medical challenges.

Latest Patents

Totaro Oka holds 2 patents related to endotoxin detoxifying materials. His latest patents include an endotoxin detoxifying material that comprises a fibrous carrier to which Polymyxin is fixed. This invention also features a method for removing endotoxin from fluids by contacting them with the detoxifying material. The innovations provide a new therapeutic approach to endotoxemia, allowing for direct and safe contact of blood with Polymyxin.

Career Highlights

Oka is currently associated with Toray Industries, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating solutions that address critical health issues related to endotoxins.

Collaborations

Throughout his career, Totaro Oka has collaborated with esteemed colleagues such as Kazuyoshi Hanazawa and Kazuo Teramoto. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Totaro Oka's contributions to endotoxin detoxification represent a significant advancement in medical technology. His innovative patents and ongoing research continue to pave the way for improved therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…